Nagano, Nahoko
Araki, Asuka
Ishikawa, Noriyoshi
Nagase, Mamiko
Adachi, Kyoichi
Ishimura, Norihisa
Ishihara, Shunji
Kinoshita, Yoshikazu
Maruyama, Riruke
Article History
Received: 26 May 2020
Accepted: 1 September 2020
First Online: 9 September 2020
Compliance with ethical standards
:
: The present study was performed at Shimane University Hospital in accordance with the Declaration of Helsinki, and the protocol was approved by the ethics committee of Shimane University School of Medicine. Written informed consent was obtained from all subjects.
: Yoshikazu Kinoshita has received research funding from EA Pharma Co., Ltd., ZERIA Pharmaceutical Co., Ltd., and honorarium from EA Pharma Co., Ltd., Astellas Pharma Inc., AstraZeneca K.K., Mylan N.V., ZERIA Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd. Shunji Ishihara has received research funding from Takeda Pharmaceutical Co., Ltd., Astellas Pharma Inc., EA Pharma Co., Ltd., Janssen Pharmaceutical K.K., ZERIA Pharmaceutical Co., Ltd., and lecture fees from Takeda Pharmaceutical Co., Ltd. The other authors have no conflicts of interest and received no financial support for this study.